SCHEMBL30908463

SCHEMBL30908463

Cc1cc(Cl)nc2cc(C=O)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 2/20 0.46
HIF1A Q16665 1/20 0.46
POLB P06746 4/20 0.46
ALDH1A1 P00352 8/20 0.41
MAPT P10636 5/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MPI P34949 1/20 0.41
LMNA P02545 1/20 0.37
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
PTK2B Q14289 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
DHFR P00374 1/20 0.36
CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17657691 0.82 POLB (0.58) KDM4EPOLBALDH1A1MAPTSMN1; SMN2
SCHEMBL30908143 0.79 ALDH1A1 (0.40) KDM4ECYP3A4CYP2C19HIF1APOLB
SCHEMBL8936155 0.78 POLB (0.72) KDM4ECYP3A4CYP2C19HIF1APOLB
SCHEMBL3420261 0.78 POLB (0.52) KDM4ECYP3A4CYP2C19HIF1APOLB
SCHEMBL5517317 0.78 MAPT (0.51) KDM4EPOLBALDH1A1MAPTSMN1; SMN2
SCHEMBL9828211 0.77 LMNA (0.47) POLBALDH1A1MAPTKMT2ALMNA
SCHEMBL1600117 0.75 KDM4E (0.49) KDM4ECYP3A4CYP2C19HIF1APOLB
SCHEMBL5434270 0.75 KDM4E (0.50) KDM4ECYP3A4CYP2C19HIF1APOLB
SCHEMBL5437258 0.75 KDM4E (0.49) KDM4ECYP3A4CYP2C19HIF1APOLB
SCHEMBL7424524 0.75 CYP2C19 (0.49) KDM4ECYP3A4CYP2C19HIF1APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024074611-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2024-04-11 WO disclosed